Search Results for: placebo

Interview with Bioheart CSO, Kristin Comella including on FDA

Kristin-Comella1

I invited the Chief Scientific Officer (CSO) of Bioheart, Kristin Comella, to do an interview after hearing some buzz that this could be a critical time for the company and that it might have been recently visited by the FDA. Note that Comella not just Bioheart CSO, but also the primary instructor for physician training in stem …

Interview with Bioheart CSO, Kristin Comella including on FDA Read More »

Gordie Howe family reportedly invested in Stemedica

Gordie_Howe_Giants

Hockey legend Gordie Howe had a devastating stroke last fall and supposedly a stem cell treatment in Mexico from for-profit stem cell businesses, Stemedica and Novastem, caused a remarkable recovery in Howe. It has been one of the most hyped stem cell stories in history. What really happened? Today a new article on a fresh investigation into this story …

Gordie Howe family reportedly invested in Stemedica Read More »

Stemedica reply to Olbermann interview on Gordie Howe

gordie-howe_001-4_3

The stem cell company Stemedica along with Mexican partner Novastem conducted a stem cell intervention on hockey legend Gordie Howe, who had suffered strokes in 2014. This situation has sparked a lot of discussion and media attention including a recent interview with Stemedica leadership on the Keith Olbermann show on ESPN. For balance and fairness …

Stemedica reply to Olbermann interview on Gordie Howe Read More »

Interview with Dr. Charles Cox on New Stem Cell Trial for Cerebral Palsy

Dr. Charles Cox at the University of Texas (UT) Health Science Center at Houston is starting a new stem cell-based clinical trial for the treatment of young children with cerebral palsy (CP). There is an urgent need for the development of new treatments for CP. You can learn more about the details of this specific …

Interview with Dr. Charles Cox on New Stem Cell Trial for Cerebral Palsy Read More »

Cell Surgical Network Interview Part 2: SVF, FDA, & Homologous Use

Today I am posting Part 2 of my interview with Drs. Lander and Berman of the Cell Surgical Network. You can read Part 1 here, which is an interesting look inside the Network. The final portion of this blog post series, Part 3, is my take on their answers and you might not be surprised that …

Cell Surgical Network Interview Part 2: SVF, FDA, & Homologous Use Read More »

Interviews

I’ve been fortunate to interview some of the greats in the stem cell field for this blog and host debates between key players. Please note that just because I have interviewed folks does not mean I agree with them or that they agree with me. The point is to establish dialogue on key issues. As …

Interviews Read More »

Interview with Arnold Caplan, Part 4: the FDA and the Future

Today is part of 4 (the last) of my interview with Dr. Arnold Caplan, MSC godfather and guru. You can read parts 1-3 of the interview here, here, and here. In this post I focus on my discussion with Caplan on translation of stem cells to patients and the FDA. During our conversation we talked about some …

Interview with Arnold Caplan, Part 4: the FDA and the Future Read More »

Interview with Arnold Caplan, Part 3: challenges & opportunities for clinical use of MSCs

I recently had a phone interview with Dr. Arnold Caplan, the founder of the MSC field. You can read parts 1 and 2 of the interview here and here. Today’s post, part 3, is focused on clinical use of MSCs. I want to start off today’s post with a wonderful quote from Caplan: “All MSCs …

Interview with Arnold Caplan, Part 3: challenges & opportunities for clinical use of MSCs Read More »